Please login to the form below

Olmesartan franchise

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olmesartan franchise was produced by Daiichi Sankyo.

Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug

The deal gives Novo Nordisk a new pipeline candidate at a time when its biopharma unit - and particularly haemophilia franchise - is facing greater competition in the market. ... With operating conditions increasingly tough for its core diabetes

Hansa Medical poaches Vifor Pharma’s CEO

Tulstrup was most recently CEO of Swiss pharmaceutical group Vifor Pharma and prior to this he served as senior vice president, global franchise head at Shire.

GSK joins Reckitt in passing on Pfizer’s consumer health unit

Yesterday, Reckitt CEO Rakesh Kapoor said that it was pulling out as it wanted to make an offer only for part of the business – rumoured to be the Advil franchise – but

Celgene bulks up pipeline again with $2.1bn Prothena deal

Celgene has been working to expand its pipeline beyond its core oncology franchise, and the deal with Prothena is the second in central nervous system diseases this month, coming after a

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Programme Executive: Salary TBC

Medical Writer, e-learning/ training, London: Excellent Salary

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Project Manager, Medical Communications, Oxford: Excellent Salary

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Medical Writer: Great salary and benefits

Group Account Director, Healthcare Brand Communications, London: Excellent Package

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Account Manager or AD - Medical Communications: Salary TBC

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Scientific Director: Great salary and bebefits

Project Manager, Medical Communications, London: Excellent Salary

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...